Alterity Therapeutics
ATHE
12 hedge funds and large institutions have $231K invested in Alterity Therapeutics in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
33% more funds holding
Funds holding: 9 → 12 (+3)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
23% less capital invested
Capital invested by funds: $299K → $231K (-$68.5K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$32K |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$13.8K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$268 |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$153 |
| 5 |
CA
CoreCap Advisors
Southfield,
Michigan
|
+$84 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$35K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$10K |
| 3 |
Morgan Stanley
New York
|
-$8.64K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $183K | -$8.64K | -2,260 | -4% |
|
|
2
Millennium Management
New York
| $34K | +$32K | +8,363 | +633% |
|
|
OMC
3
Old Mission Capital
Chicago,
Illinois
| $12.6K | +$13.8K | +3,609 | New |
|
|
PCA
4
Providence Capital Advisors
Charlotte,
North Carolina
| $696 | – | – | – |
|
|
5
BNP Paribas Financial Markets
Paris,
France
| $244 | +$268 | +70 | New |
|
|
6
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $140 | +$153 | +40 | New |
|
|
SWM
7
Sugarloaf Wealth Management
Duluth,
Georgia
| $116 | – | – | – |
|
|
CA
8
CoreCap Advisors
Southfield,
Michigan
| $75 | +$84 | +22 | New |
|
|
CAS
9
Coppell Advisory Solutions
Coppell,
Texas
| $52 | +$57 | +15 | New |
|
|
CASC
10
Coppell Advisory Solutions Corp
Coppell,
Texas
| $52 | +$57 | +15 | New |
|
|
SPIA
11
Steward Partners Investment Advisory
New York
| $21 | – | – | – |
|
|
12
Envestnet Asset Management
Chicago,
Illinois
| – | -$35K | -7,807 | Closed |
|
|
TSS
13
Two Sigma Securities
New York
| – | -$10K | -2,319 | Closed |
|
|
14
Geode Capital Management
Boston,
Massachusetts
| – | -$5K | -1,213 | Closed |
|
ATHE Hedge Fund Activity: Q4 2022 in Review
12 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q4 2022, worth a combined $231K — down 23% from $299K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ATHE positions and 3 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Millennium Management, adding an estimated $32K. The largest seller was Envestnet Asset Management, exiting entirely with an estimated $35K sold.
- 12 institutional investors held Alterity Therapeutics (ATHE) as of Q4 2022, up from 9 in Q3 2022.
- Funds reported $231K of Alterity Therapeutics stock for Q4 2022, down 23% quarter-over-quarter.
- 6 funds opened new Alterity Therapeutics positions in Q4 2022 and 3 closed out, a net change of +3 holders.
- The largest Alterity Therapeutics buyer in Q4 2022 was Millennium Management, an estimated $32K added.
- The largest Alterity Therapeutics seller in Q4 2022 was Envestnet Asset Management, an estimated $35K sold.
Based on aggregated 13F filings for Q4 2022.